131 related articles for article (PubMed ID: 10393367)
1. HLA antigens in Iranian patients with B-cell chronic lymphocytic leukemia.
Moazzeni SM; Amirzargar AA; Shokri F
Pathol Oncol Res; 1999; 5(2):142-5. PubMed ID: 10393367
[TBL] [Abstract][Full Text] [Related]
2. Frequency analysis of HLA class I alleles in Iranian patients with progressive and non-progressive chronic lymphocytic leukemia.
Hojjat-Farsangi M; Razavi SM; Sharifian RA; Shokri F
Hum Immunol; 2014 Feb; 75(2):170-5. PubMed ID: 24269699
[TBL] [Abstract][Full Text] [Related]
3. [Association between HLA antigens and leukemia in the population of Vojvodina].
Vojvodić S; Belić B; Popović S
Med Pregl; 2001; 54(3-4):128-34. PubMed ID: 11759203
[TBL] [Abstract][Full Text] [Related]
4. Association of chronic lymphocytic leukemia with specific alleles of the HLA-DR4:DR53:DQ8 haplotype in German patients.
Machulla HK; Müller LP; Schaaf A; Kujat G; Schönermarck U; Langner J
Int J Cancer; 2001 Apr; 92(2):203-7. PubMed ID: 11291046
[TBL] [Abstract][Full Text] [Related]
5. Comparative expression of major histocompatibility complex (MHC) antigens on CD5+ and CD5- B cells in patients with chronic lymphocytic leukaemia (CLL).
Nouri AM; Smith S; Oliver TR; Newland AC; Macey MG
Eur J Cancer; 1998 Sep; 34(10):1618-22. PubMed ID: 9893639
[TBL] [Abstract][Full Text] [Related]
6. HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?
Erikci AA; Karagoz B; Ozyurt M; Ozturk A; Kilic S; Bilgi O
Hematology; 2009 Apr; 14(2):101-5. PubMed ID: 19298722
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen class II allele association to disease progression in Iranian patients with chronic lymphocytic leukemia.
Hojjat-Farsangi M; Jeddi-Tehrani M; Amirzargar AA; Razavi SM; Sharifian RA; Rabbani H; Shokri F
Hum Immunol; 2008 Oct; 69(10):666-74. PubMed ID: 18722491
[TBL] [Abstract][Full Text] [Related]
8. The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL).
Giannopoulos K; Schmitt M; Kowal M; Własiuk P; Bojarska-Junak A; Roliński J; Dmoszyńska A
Leuk Res; 2008 Dec; 32(12):1815-9. PubMed ID: 18499249
[TBL] [Abstract][Full Text] [Related]
9. Analysis of HLA-G gene expression in B-lymphocytes from chronic lymphocytic leukemia patients.
Rezvany MR; Kazemi A; Hajifathali A; Kaviani S; Mellstedt H
Iran Biomed J; 2007 Apr; 11(2):125-129. PubMed ID: 18051955
[TBL] [Abstract][Full Text] [Related]
10. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
[TBL] [Abstract][Full Text] [Related]
11. Association of HLA class I antigens with diffuse panbronchiolitis in Korean patients.
Park MH; Kim YW; Yoon HI; Yoo CG; Han SK; Shim YS; Kim WD
Am J Respir Crit Care Med; 1999 Feb; 159(2):526-9. PubMed ID: 9927368
[TBL] [Abstract][Full Text] [Related]
12. Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate.
Goddard RV; Prentice AG; Copplestone JA; Kaminski ER
Clin Exp Immunol; 2001 Oct; 126(1):16-28. PubMed ID: 11678895
[TBL] [Abstract][Full Text] [Related]
13. HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implications.
Rebmann V; Nückel H; Dührsen U; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):430-5. PubMed ID: 17683947
[TBL] [Abstract][Full Text] [Related]
14. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia.
Nückel H; Rebmann V; Dürig J; Dührsen U; Grosse-Wilde H
Blood; 2005 Feb; 105(4):1694-8. PubMed ID: 15466928
[TBL] [Abstract][Full Text] [Related]
15. Leukemia specific loss of heterozygosity of MHC in a CLL patient: disease state impacts timing of confirmatory typing.
Coppage M; Iqbal A; Ahmad A; Becker MW
Hum Immunol; 2013 Jan; 74(1):41-4. PubMed ID: 23085343
[TBL] [Abstract][Full Text] [Related]
16. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
[TBL] [Abstract][Full Text] [Related]
17. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
Karabon L; Jedynak A; Giebel S; Wołowiec D; Kielbinski M; Woszczyk D; Kapelko-Slowik K; Kuliczkowski K; Frydecka I
Tissue Antigens; 2011 Aug; 78(2):129-38. PubMed ID: 21726204
[TBL] [Abstract][Full Text] [Related]
18. NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G.
Maki G; Hayes GM; Naji A; Tyler T; Carosella ED; Rouas-Freiss N; Gregory SA
Leukemia; 2008 May; 22(5):998-1006. PubMed ID: 18288133
[TBL] [Abstract][Full Text] [Related]
19. Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy.
Hoogendoorn M; Wolbers JO; Smit WM; Schaafsma MR; Barge RM; Willemze R; Falkenburg JH
Leukemia; 2004 Jul; 18(7):1278-87. PubMed ID: 15116118
[TBL] [Abstract][Full Text] [Related]
20. A highly sensitive, rapid screening method for the detection of antibodies directed against HLA class I and II antigens.
Harmer AW; Sutton M; Bayne A; Vaughan RW; Welsh KI
Transpl Int; 1993; 6(5):277-80. PubMed ID: 8216704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
